Why is Medicamen Biotec falling/rising?

As of 17-Sep, Medicamen Biotech Ltd's stock price is currently at Rs 341.50, reflecting an increase of Rs 3.5 or 1.04%. The stock has shown a trend reversal by gaining after four consecutive days of decline, and it outperformed its sector by 1% today. However, it remains close to its 52-week low, just 1.02% away from Rs 338. Despite this positive movement today, the stock has underperformed significantly over the longer term, with a year-to-date decline of 32.94% compared to a 5.83% increase in the benchmark index. Additionally, the stock is trading below all its moving averages, indicating a bearish trend overall. There is a notable increase in investor participation, with delivery volume rising by 65.95% against the 5-day average, which may suggest growing interest despite the stock's overall poor performance.
Broader Market Context: In the short term, Medicamen Biotech's stock has declined by 1.97% over the past week, while the benchmark Sensex has increased by 1.56%. This stark contrast highlights the stock's struggles relative to the broader market. Over the past month, the stock has decreased by 3.61%, while the Sensex has gained 2.60%, further emphasizing the underperformance of Medicamen Biotech. The significant disparity in returns over various periods, particularly the 3-year return of -67.57% compared to the Sensex's 40.54% increase, underscores the challenges the company faces in attracting investor confidence amidst a generally positive market environment.